| 000 | 01618 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518025439.0 | ||
| 264 | 0 | _c20200706 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a2192-2659 | ||
| 024 | 7 |
_a10.1002/adhm.201801261 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Haiwei | |
| 245 | 0 | 0 |
_aPropranolol-Loaded Mesoporous Silica Nanoparticles for Treatment of Infantile Hemangiomas. _h[electronic resource] |
| 260 |
_bAdvanced healthcare materials _c05 2019 |
||
| 300 |
_ae1801261 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aDrug Carriers _xchemistry |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aHemangioma _xdrug therapy |
| 650 | 0 | 4 | _aHuman Umbilical Vein Endothelial Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNanoparticles _xadverse effects |
| 650 | 0 | 4 |
_aPolyvinyl Alcohol _xchemistry |
| 650 | 0 | 4 | _aPorosity |
| 650 | 0 | 4 |
_aPropranolol _xchemistry |
| 650 | 0 | 4 |
_aSilicon Dioxide _xchemistry |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aWang, Xuan | |
| 700 | 1 | _aZheng, Jiawei | |
| 700 | 1 | _aZhang, Ling | |
| 700 | 1 | _aLi, Xiaoming | |
| 700 | 1 | _aYuan, Wei-En | |
| 700 | 1 | _aLiu, Xuejian | |
| 773 | 0 |
_tAdvanced healthcare materials _gvol. 8 _gno. 9 _gp. e1801261 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/adhm.201801261 _zAvailable from publisher's website |
| 999 |
_c29445743 _d29445743 |
||